Tissue Sectioning Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 0.84 Billion |
| Market Size (2030) | USD 1.10 Billion |
| CAGR (2025 - 2030) | 5.70% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Tissue Sectioning Market Analysis
The Tissue Sectioning Market size is estimated at USD 0.84 billion in 2025, and is expected to reach USD 1.10 billion by 2030, at a CAGR of 5.7% during the forecast period (2025-2030).
Factors such as the increasing demand for tissue biopsies to diagnose cancer and other diseases and the rising adoption of personalized therapeutics and diagnostics are propelling the market's growth.
The rising incidence of cancer is significantly impacting the tissue sectioning market, which plays a crucial role in diagnosing and researching cancer. As cancer rates increase, there is a growing need for accurate and efficient diagnostic procedures, driving demand for advanced tissue sectioning technologies. For instance, according to the Indian Council of Medical Research (ICMR), in February 2024, India recorded 1,461,427 cancer cases. Furthermore, approximately one in nine Indians are projected to be diagnosed with cancer during their lifetime.
Additionally, according to the March 2022 data from the World Health Organization (WHO), Germany recorded 605,805 cancer cases in 2022, of which 74,016 were breast cancer cases and 65,269 were prostate cancer cases. Thus, the growing number of cancer cases and advancements in diagnostic techniques drive significant growth in the tissue sectioning market.
Personalized medicines that rely on precise tumor genetic profiling for tailored treatments are expected to boost the market by elevating the need for comprehensive tissue testing to support individualized cancer diagnosis and therapy. For instance, an article published in the Journal of Personalized Medicine in February 2023 described a novel medical approach emphasizing tailoring cancer treatment. This approach aimed to improve the efficacy of anti-cancer therapies while minimizing adverse effects. Such advantages are expected to impact the tissue sectioning market positively.
Furthermore, manufacturers are launching various technologically advanced microtomes to sustain themselves in the global market. For instance, in April 2023, LLS ROWIAK LaserLab Solution launched its new LLS ROWIAK LaserMicrotome LM350. This new microtome uses laser technology to cut tissue sections, resulting in higher-quality sections with less tissue damage. Such product launches broaden the application of tissue sectioning and thus positively impact the market.
Hence, the factors mentioned above, such as the increasing demand for tissue tests in cancer diagnosis, increasing preferences for personalized therapeutics, and manufacturers focusing on launches, are expected to boost the market's growth. However, a lack of skilled personnel and inherent challenges related to tissue processing are likely to hamper such growth over the forecast period.
Tissue Sectioning Market Trends
The Instruments Segment is Expected to Witness Significant Growth Over the Forecast Period
Instruments, such as microtomes and cryostats, are critical for accurately sectioning tissue samples, which is fundamental for diagnosing diseases, especially cancer. The precision and quality of these instruments directly impact diagnostic accuracy. Different types of microtomes serve purposes such as sliding, rotating, freezing, and lasering.
An increasing number of research studies, coupled with the development of advanced cryostat technology, is anticipated to drive the segment's growth. For instance, in May 2024, the National Composites Centre (NCC) in Bristol, United Kingdom, developed an innovative cryostat and testing method. This advancement enables the rapid and cost-effective assessment of composite materials' performance at cryogenic temperatures. The device and its accompanying test method provide an efficient solution for screening a wide range of materials, identifying those most suitable for detailed testing using conventional methods. Therefore, by enabling rapid and cost-effective performance assessment of materials at extreme temperatures, these innovations demonstrate the ongoing progress in precision and efficiency in the field, boosting market expansion over the studied period.
Continuous innovations in sectioning instruments, including automation and enhanced precision features, drive demand in the segment studied. Advanced instruments improve workflow efficiency and diagnostic outcomes, making them integral to modern laboratories. Manufacturers focusing on technological advancements and continuous innovations in sectioning instruments by launching products are driving demand in the segment. For instance, in February 2023, Precisionary Instruments LLC launched three new rotary microtome models, including the manual RF-600, the semi-automated RF-800, and the fully automated RF-1000. The RF-1000 features fully automated cutting capabilities, which can be controlled via a touchscreen, a side control panel, or a foot pedal. Hence, launching new rotary microtome models with advanced technological advancements may drive the segment's growth over the forecast period.
Furthermore, the government authorities are focusing on cancer research through increased funding. For instance, according to March 2024 updates from the National Institute of Health, the United States government invested USD 6.7 billion and USD 7.9 billion in 2022 and 2023 for cancer research. This boost in research activities may lead to greater adoption of sophisticated sectioning instruments, expanding the segment's growth over the studied period.
Thus, increasing research studies and manufacturers focusing on technological advancements and acquisitions are expected to augment the segment's growth, further boosting the market's growth.
North America is Expected to Hold a Significant Market Share During the Forecast Period
North America is expected to hold a significant market share in the tissue sectioning market over the forecast period due to the growing incidence of cancer and technological advancements. Additionally, manufacturers are focusing on launches and product approvals, which are anticipated to further propel the market in this region.
The United States has a high prevalence of cancer. As cases increase, the demand for accurate diagnosis and treatment planning also rises. For instance, according to the data published by the American Cancer Society in March 2024, the United States is projected to record over 2,001,140 new cancer cases in 2024. Notably, 88% of cancer diagnoses in the country occur in individuals aged 50 and above, with 57% being 65 or older. Facilitated by examining thin tissue slices through tissue sectioning, precise cancer diagnosis and personalized treatment strategies are anticipated to drive the market studied in the United States in the coming years.
Advancements in technology are set to drive the US tissue sectioning market by introducing innovations that enhance precision, efficiency, and overall performance. Key developments such as automated sectioning instruments, advanced staining techniques, organ-on-a-chip technology, and improved imaging technologies contribute to more accurate and efficient tissue analysis. For instance, as per the article published in Elsevier in June 2023, personalized medicine gained significant attention. This approach predicts an individual’s disease susceptibility by analyzing their unique immune genomics, which is then used to develop innovative, customized treatments. Advancements in organ-on-a-chip technology and 3D bioprinting are set to transform the development of personalized tissue models for infectious diseases. These innovations strengthen preparedness and response strategies for future pandemics, thereby accelerating market growth during the forecast period.
Companies are focusing on launching and getting FDA approval to develop their tissue sectioning technologies. For instance, in November 2022, Clarapath Inc. filed for FDA approval of its new robotic instrument, SectionStar, a fully autonomous system that increases the reliability and efficiency of pathology lab operations by standardizing the quality of tissue sections.
Thus, the rising number of cancer cases, technological advancements in the region, the growing launch of new products, and regulatory approval are likely to promote market growth in North America over the forecast period.
Tissue Sectioning Industry Overview
The tissue sectioning market is semi-consolidated and consists of several major players. Strategic initiatives taken by these companies, such as product launches and mergers and acquisitions, are expected to impact the market positively. Some of the significant players in the market are AGD Biomedicals (P) Ltd, Amos Scientific Pty Ltd, Boeckeler Instruments, Inc., Danaher Corporation, Diapath SpA, LLS ROWIAK LaserLabSolutions GmbH, Sakura Finetek Japan Co. Ltd, SLEE medical GmbH, SM Scientific Instruments Pvt. Ltd, and Thermo Fisher Scientific Inc.
Tissue Sectioning Market Leaders
-
Thermo Fisher Scientific Inc.
-
Danaher Corporation
-
LLS ROWIAK LaserLabSolutions GmbH
-
Sakura Finetek Japan Co.,Ltd.
-
Diapath S.p.A.
- *Disclaimer: Major Players sorted in no particular order
Tissue Sectioning Market News
- April 2024: Clarapath, a pioneering medical robotics firm, forged a strategic alliance with the renowned Mayo Clinic. Clarapath's SectionStar is a groundbreaking FDA-approval pending all-in-one tissue sectioning and transfer system that enhances capacity, reliability, and consistency and reduces the dependency on specialized labor. By merging Clarapath's cutting-edge tissue solutions and expertise with Mayo Clinic's clinical insights, this collaboration aims to revolutionize histology processes through quality, safety, cost-efficiency, and throughput enhancements.
- March 2024: Leica Microsystems introduced UC Enuity, a state-of-the-art ultramicrotome for electron microscopy sample preparation. This new launch represents a significant advancement since it focuses on automation and reduces the entry barrier for researchers and technicians. UC Enuity allows users of all skill levels to achieve precise and reproducible results with minimal training.
Tissue Sectioning Industry Segmentation
As per the scope of the report, tissue sectioning is the process of cutting thin slices, known as sections or slides, from biological tissues for microscopic examination. These sections study tissue structure, composition, and pathology at a cellular level, aiding in various fields such as pathology, biomedical research, and drug development.
The tissue sectioning market is segmented by product (instruments and accessories and consumables), technology (automatic, semiautomatic, and manual), end user (academic and research institutes, clinical laboratories, hospital laboratories, and pharmaceutical and biotechnology companies), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers market sizes and forecasts in terms of value (USD) for the above segments.
| By Product | Instruments | Cryostat Microtomes | |
| Rotary Microtome | |||
| Sliding Microtome | |||
| Tissue Processors | |||
| Other Instruments (Paraffin Dispenser, Slide Warmer, and Tissue Floating Bath) | |||
| Accessories and Consumables | |||
| By Technology | Automatic | ||
| Semiautomatic | |||
| Manual | |||
| By End User | Academic and Research Institutes | ||
| Clinical Laboratories | |||
| Hospital Laboratories | |||
| Pharmaceutical and Biotechnology Companies | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Tissue Sectioning Market Research FAQs
How big is the Tissue Sectioning Market?
The Tissue Sectioning Market size is expected to reach USD 0.84 billion in 2025 and grow at a CAGR of 5.70% to reach USD 1.10 billion by 2030.
What is the current Tissue Sectioning Market size?
In 2025, the Tissue Sectioning Market size is expected to reach USD 0.84 billion.
Who are the key players in Tissue Sectioning Market?
Thermo Fisher Scientific Inc., Danaher Corporation, LLS ROWIAK LaserLabSolutions GmbH, Sakura Finetek Japan Co.,Ltd. and Diapath S.p.A. are the major companies operating in the Tissue Sectioning Market.
Which is the fastest growing region in Tissue Sectioning Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Tissue Sectioning Market?
In 2025, the North America accounts for the largest market share in Tissue Sectioning Market.
What years does this Tissue Sectioning Market cover, and what was the market size in 2024?
In 2024, the Tissue Sectioning Market size was estimated at USD 0.79 billion. The report covers the Tissue Sectioning Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Tissue Sectioning Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Tissue Sectioning Industry Report
Statistics for the 2025 Tissue Sectioning market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Tissue Sectioning analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
